ApprovalTrail

Approval · Notice of Compliance 28845 · 2022

FML: Notice of Compliance 28845

Issued August 29, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
28845
Date
August 29, 2022
Company
AbbVie CorporationSaint-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Merger/Buy-out

Products in this notice

BrandDINStatus today
FML00247855Marketed

Medicinal ingredients